Chanelle Group
↗Loughrea, Ireland
Chanelle Group is a leading Irish-owned pharmaceutical company headquartered in Loughrea, County Galway. Founded in 1985, the company specializes in the development, manufacturing, and distribution of both human and veterinary pharmaceutical products, holding an extensive portfolio of licenses and exporting to over 90 countries worldwide.
In early 2024, the company was acquired by the British private equity firm Exponent. Despite the acquisition, Chanelle Group continues to operate as an Irish-managed entity, maintaining its focus on generic drug development, contract manufacturing, and R&D for both animal and human health sectors.
CLASSIFICATION
Company Type:CDMO
Therapeutic Areas:-
Industry:Pharmaceuticals
Sub-Industry:Generic Pharmaceuticals (Human & Veterinary)
SIZE & FINANCIALS
Employees:501-1000
Revenue:$100M-$200M
Founded:1985
Ownership:subsidiary
Status:operating
FUNDING
Investors:Exponent
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Exponent
Acquired By:Exponent (2024-02-01)
Key Partnerships:SAP (Digital transformation partnership)
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Michael Burke - Founder
Scientific Founders:Michael Burke
LINKS
Website:chanellegroup.ie
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Chanelle Group and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Chanelle Group. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.